drugset / Trial / NCT05327972

DEgenerative ROtator Cuff Disease and Botulinum TOXin

NCT05327972 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the study is to assess the effectiveness of botulinum toxin in persistent shoulder pain due to degenerative rotator cuff disease.

Timeline

Start
2023-01-20
Primary completion
2027-02
Completion
2027-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 100 iu Intramuscular

Indications